Management and outcome of 11 pregnancies in women with polycythemia vera

Leuk Res. 2019 Jun:81:25-26. doi: 10.1016/j.leukres.2019.04.003. Epub 2019 Apr 8.

Authors

E M Elli¹, E Diral², C Gambacorti-Passerini², R Calori³, I Carmosino⁴, M Breccia⁴, R Latagliata⁴, A Di Veroli⁵

Affiliations

¹ Hematology Division and Bone Marrow Unit, Ospedale San Gerardo, Monza, Italy. Electronic address: [email protected].
² Hematology Division and Bone Marrow Unit, Ospedale San Gerardo, Monza, Italy.
³ Oncology Department, Ospedale Civile, Vimercate, Italy.
⁴ Dipartimento di Biotecnologie Cellulari ed Ematologia, Università Sapienza, Rome, Italy.
⁵ Hematology Division, Ospedale Belcolle, Viterbo, Italy.

PMID: 30986630
DOI: 10.1016/j.leukres.2019.04.003

No abstract available

Publication types

Letter

MeSH terms

Adult
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Anticoagulants / therapeutic use
Aspirin / therapeutic use*
Disease Management
Drug Therapy, Combination
Female
Follow-Up Studies
Heparin, Low-Molecular-Weight / therapeutic use*
Humans
Polycythemia Vera / drug therapy*
Polycythemia Vera / physiopathology
Pregnancy
Pregnancy Complications, Neoplastic / drug therapy*
Pregnancy Complications, Neoplastic / etiology
Pregnancy Complications, Neoplastic / pathology
Prognosis
Retrospective Studies
Young Adult

Substances

Anti-Inflammatory Agents, Non-Steroidal
Anticoagulants
Heparin, Low-Molecular-Weight
Aspirin